Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
  • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
  • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
  • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
  • C07H15/02—Acyclic radicals, not substituted by cyclic structures
  • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/04—Antibacterial agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
  • C07H15/20—Carbocyclic rings
  • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
  • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
  • C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
  • C07H15/20—Carbocyclic rings
  • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
  • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
  • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
  • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
  • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
  • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Genetics & Genomics (AREA)
• Biotechnology (AREA)
• Biochemistry (AREA)
• Engineering & Computer Science (AREA)
• Oncology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Communicable Diseases (AREA)
• Epidemiology (AREA)
• Crystallography & Structural Chemistry (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Saccharide Compounds (AREA)
• Cephalosporin Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Applications Claiming Priority (3)

Publications (3)

Family

ID=57884581

Family Applications (1)

Country Status (21)

Families Citing this family (6)

Family Cites Families (19)

• 2016
  • 2016-07-29 EP EP19154615.9A patent/EP3498723A1/en active Pending
  • 2016-07-29 AR ARP160102333A patent/AR105547A1/es active IP Right Grant
  • 2016-07-29 US US15/747,581 patent/US10617704B2/en active Active
  • 2016-07-29 AU AU2016300993A patent/AU2016300993B2/en active Active
  • 2016-07-29 JP JP2017530947A patent/JP6938376B2/ja active Active
  • 2016-07-29 SG SG11201800510WA patent/SG11201800510WA/en unknown
  • 2016-07-29 SG SG10201913231RA patent/SG10201913231RA/en unknown
  • 2016-07-29 RU RU2018107150A patent/RU2751634C2/ru active
  • 2016-07-29 MY MYPI2018700342A patent/MY186959A/en unknown
  • 2016-07-29 EP EP16830631.4A patent/EP3330275A4/en not_active Withdrawn
  • 2016-07-29 MX MX2018001022A patent/MX383996B/es unknown
  • 2016-07-29 KR KR1020187005745A patent/KR102590696B1/ko active Active
  • 2016-07-29 WO PCT/JP2016/072400 patent/WO2017018528A1/ja not_active Ceased
  • 2016-07-29 CN CN201680044421.1A patent/CN108026133B/zh active Active
  • 2016-07-29 UA UAA201802040A patent/UA123629C2/uk unknown
  • 2016-07-29 CA CA2993425A patent/CA2993425A1/en active Pending
  • 2016-07-29 TW TW105124162A patent/TWI699372B/zh active
• 2018
  • 2018-01-25 IL IL257151A patent/IL257151B/en active IP Right Grant
  • 2018-01-25 PH PH12018500202A patent/PH12018500202B1/en unknown
  • 2018-01-26 CL CL2018000228A patent/CL2018000228A1/es unknown
  • 2018-01-28 SA SA518390825A patent/SA518390825B1/ar unknown
  • 2018-02-06 CO CONC2018/0001237A patent/CO2018001237A2/es unknown
  • 2018-02-26 ZA ZA2018/01312A patent/ZA201801312B/en unknown
• 2020
  • 2020-01-22 US US16/749,191 patent/US11135234B2/en active Active

Also Published As

Similar Documents